Functional Dyspepsia Drug Industry Research Report 2025

Summary

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

According to APO Research, the global Functional Dyspepsia Drug market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Functional Dyspepsia Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Functional Dyspepsia Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Functional Dyspepsia Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Functional Dyspepsia Drug include Bayer, Sumitomo, Cadila Pharmaceuticals, Teva, Johnson & Johnson, Pfizer, Sanofi, AstraZeneca and Jiangsu Aosaikang Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Functional Dyspepsia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Dyspepsia Drug.

The report will help the Functional Dyspepsia Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Functional Dyspepsia Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Functional Dyspepsia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Functional Dyspepsia Drug Segment by Company

Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Functional Dyspepsia Drug Segment by Type

Prokinetic Drugs
Gastric Antisecretory Drugs
Others
Functional Dyspepsia Drug Segment by Application

Hospitals
Drugstores
Functional Dyspepsia Drug Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Functional Dyspepsia Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Functional Dyspepsia Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Functional Dyspepsia Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Functional Dyspepsia Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Functional Dyspepsia Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Functional Dyspepsia Drug Market Size (2020-2031)
2.2.2 Global Functional Dyspepsia Drug Sales (2020-2031)
2.2.3 Global Functional Dyspepsia Drug Market Average Price (2020-2031)
2.3 Functional Dyspepsia Drug by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Prokinetic Drugs
2.3.3 Gastric Antisecretory Drugs
2.3.4 Others
2.4 Functional Dyspepsia Drug by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospitals
2.4.3 Drugstores
3 Market Competitive Landscape by Manufacturers
3.1 Global Functional Dyspepsia Drug Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Functional Dyspepsia Drug Sales (M Units) of Manufacturers (2020-2025)
3.3 Global Functional Dyspepsia Drug Revenue of Manufacturers (2020-2025)
3.4 Global Functional Dyspepsia Drug Average Price by Manufacturers (2020-2025)
3.5 Global Functional Dyspepsia Drug Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Functional Dyspepsia Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Functional Dyspepsia Drug, Product Type & Application
3.8 Global Manufacturers of Functional Dyspepsia Drug, Established Date
3.9 Global Functional Dyspepsia Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Bayer
4.1.1 Bayer Company Information
4.1.2 Bayer Business Overview
4.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Bayer Functional Dyspepsia Drug Product Portfolio
4.1.5 Bayer Recent Developments
4.2 Sumitomo
4.2.1 Sumitomo Company Information
4.2.2 Sumitomo Business Overview
4.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Sumitomo Functional Dyspepsia Drug Product Portfolio
4.2.5 Sumitomo Recent Developments
4.3 Cadila Pharmaceuticals
4.3.1 Cadila Pharmaceuticals Company Information
4.3.2 Cadila Pharmaceuticals Business Overview
4.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
4.3.5 Cadila Pharmaceuticals Recent Developments
4.4 Teva
4.4.1 Teva Company Information
4.4.2 Teva Business Overview
4.4.3 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Teva Functional Dyspepsia Drug Product Portfolio
4.4.5 Teva Recent Developments
4.5 Johnson & Johnson
4.5.1 Johnson & Johnson Company Information
4.5.2 Johnson & Johnson Business Overview
4.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Portfolio
4.5.5 Johnson & Johnson Recent Developments
4.6 Pfizer
4.6.1 Pfizer Company Information
4.6.2 Pfizer Business Overview
4.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Pfizer Functional Dyspepsia Drug Product Portfolio
4.6.5 Pfizer Recent Developments
4.7 Sanofi
4.7.1 Sanofi Company Information
4.7.2 Sanofi Business Overview
4.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Sanofi Functional Dyspepsia Drug Product Portfolio
4.7.5 Sanofi Recent Developments
4.8 AstraZeneca
4.8.1 AstraZeneca Company Information
4.8.2 AstraZeneca Business Overview
4.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.8.4 AstraZeneca Functional Dyspepsia Drug Product Portfolio
4.8.5 AstraZeneca Recent Developments
4.9 Jiangsu Aosaikang Pharma
4.9.1 Jiangsu Aosaikang Pharma Company Information
4.9.2 Jiangsu Aosaikang Pharma Business Overview
4.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio
4.9.5 Jiangsu Aosaikang Pharma Recent Developments
4.10 Eisai
4.10.1 Eisai Company Information
4.10.2 Eisai Business Overview
4.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Eisai Functional Dyspepsia Drug Product Portfolio
4.10.5 Eisai Recent Developments
4.11 Kyowa Kirin Pharmaceuticals
4.11.1 Kyowa Kirin Pharmaceuticals Company Information
4.11.2 Kyowa Kirin Pharmaceuticals Business Overview
4.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
4.11.5 Kyowa Kirin Pharmaceuticals Recent Developments
4.12 Hanmi Pharm
4.12.1 Hanmi Pharm Company Information
4.12.2 Hanmi Pharm Business Overview
4.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Portfolio
4.12.5 Hanmi Pharm Recent Developments
5 Global Functional Dyspepsia Drug Market Scenario by Region
5.1 Global Functional Dyspepsia Drug Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Functional Dyspepsia Drug Sales by Region: 2020-2031
5.2.1 Global Functional Dyspepsia Drug Sales by Region: 2020-2025
5.2.2 Global Functional Dyspepsia Drug Sales by Region: 2026-2031
5.3 Global Functional Dyspepsia Drug Revenue by Region: 2020-2031
5.3.1 Global Functional Dyspepsia Drug Revenue by Region: 2020-2025
5.3.2 Global Functional Dyspepsia Drug Revenue by Region: 2026-2031
5.4 North America Functional Dyspepsia Drug Market Facts & Figures by Country
5.4.1 North America Functional Dyspepsia Drug Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Functional Dyspepsia Drug Sales by Country (2020-2031)
5.4.3 North America Functional Dyspepsia Drug Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Functional Dyspepsia Drug Market Facts & Figures by Country
5.5.1 Europe Functional Dyspepsia Drug Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Functional Dyspepsia Drug Sales by Country (2020-2031)
5.5.3 Europe Functional Dyspepsia Drug Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Functional Dyspepsia Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Functional Dyspepsia Drug Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Functional Dyspepsia Drug Sales by Country (2020-2031)
5.6.3 Asia Pacific Functional Dyspepsia Drug Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Functional Dyspepsia Drug Market Facts & Figures by Country
5.7.1 South America Functional Dyspepsia Drug Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Functional Dyspepsia Drug Sales by Country (2020-2031)
5.7.3 South America Functional Dyspepsia Drug Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Functional Dyspepsia Drug Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2020-2031)
5.8.3 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Functional Dyspepsia Drug Sales by Type (2020-2031)
6.1.1 Global Functional Dyspepsia Drug Sales by Type (2020-2031) & (M Units)
6.1.2 Global Functional Dyspepsia Drug Sales Market Share by Type (2020-2031)
6.2 Global Functional Dyspepsia Drug Revenue by Type (2020-2031)
6.2.1 Global Functional Dyspepsia Drug Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Type (2020-2031)
6.3 Global Functional Dyspepsia Drug Price by Type (2020-2031)
7 Segment by Application
7.1 Global Functional Dyspepsia Drug Sales by Application (2020-2031)
7.1.1 Global Functional Dyspepsia Drug Sales by Application (2020-2031) & (M Units)
7.1.2 Global Functional Dyspepsia Drug Sales Market Share by Application (2020-2031)
7.2 Global Functional Dyspepsia Drug Revenue by Application (2020-2031)
7.2.1 Global Functional Dyspepsia Drug Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Application (2020-2031)
7.3 Global Functional Dyspepsia Drug Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Functional Dyspepsia Drug Value Chain Analysis
8.1.1 Functional Dyspepsia Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Functional Dyspepsia Drug Production Mode & Process
8.2 Functional Dyspepsia Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Functional Dyspepsia Drug Distributors
8.2.3 Functional Dyspepsia Drug Customers
9 Global Functional Dyspepsia Drug Analyzing Market Dynamics
9.1 Functional Dyspepsia Drug Industry Trends
9.2 Functional Dyspepsia Drug Industry Drivers
9.3 Functional Dyspepsia Drug Industry Opportunities and Challenges
9.4 Functional Dyspepsia Drug Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings